Introduction: Who Should Undergo Diagnostics

Any person experiencing bleeding from the vaginal area that does not align with their normal menstrual pattern should consider seeking medical evaluation. This is particularly important if you notice bleeding between your regular periods, after sexual intercourse, or after you have gone through menopause. While occasional light spotting may not always be cause for alarm, persistent or heavy bleeding deserves medical attention.^[1]

You should seek diagnostic evaluation if your bleeding is heavy enough that you need to change a pad or tampon every hour for several consecutive hours, or if you pass blood clots the size of a quarter or larger. Bleeding that lasts longer than seven days, or periods that occur more frequently than every 21 days or less often than every 35 days, also warrant investigation. Young girls who experience bleeding before age nine and women who have gone three to six months without a period should also be evaluated.^[4]

Pregnant individuals who experience any vaginal bleeding should contact their healthcare provider immediately, as this can sometimes indicate complications such as miscarriage (pregnancy loss before 20 weeks), ectopic pregnancy (when a fertilized egg grows outside the uterus), or problems with the placenta. Even light bleeding during pregnancy should not be ignored.^[7]

If your bleeding is accompanied by severe pain in your lower abdomen or pelvis, dizziness, lightheadedness, or symptoms of anemia (a condition where you have low red blood cell count, causing fatigue and weakness), you should seek immediate medical care. Similarly, if bleeding interferes with your daily activities—forcing you to miss work, avoid social situations, or stay home—it is time to consult a healthcare provider.^[1]

Classic Diagnostic Methods

When you visit a healthcare provider with concerns about vaginal bleeding, the diagnostic process typically begins with a thorough discussion of your medical history and symptoms. Your provider will ask detailed questions about when the bleeding occurs, how heavy it is, how long it lasts, and whether it is accompanied by other symptoms such as pain, unusual discharge, or fever. They may ask you to describe how many pads or tampons you use and whether you need to change them during the night.^[4]

A physical examination is usually the next step, which includes a pelvic exam. During this examination, your healthcare provider inspects the external genital area, vagina, and cervix to identify any visible sources of bleeding such as lesions, infections, or growths. The exam helps determine whether the bleeding is coming from the vagina, cervix, or uterus, or possibly from the bladder or bowel. Sometimes bleeding that appears vaginal may actually originate from these other areas.^[2]

Blood tests are commonly ordered to help identify the cause of bleeding and assess its impact on your health. A complete blood count (CBC) checks for anemia and measures your iron levels, which can be depleted by heavy or prolonged bleeding. Hormone level tests may be performed to check thyroid function or to evaluate estrogen and progesterone levels, as hormonal imbalances are a frequent cause of abnormal bleeding. A pregnancy test is also standard practice for anyone of reproductive age, as pregnancy complications can cause bleeding.^[4]

A Pap test, also called a Papanicolaou smear, involves collecting cells from your cervix to check for inflammation, infection, or abnormal changes that could be precancerous or cancerous. This test is particularly important for identifying cervical causes of bleeding. In some cases, testing for human papillomavirus (HPV) or sexually transmitted infections (STIs) may also be recommended, as infections can cause bleeding.^[12]

Ultrasound imaging is one of the most commonly used diagnostic tools for evaluating vaginal bleeding. A pelvic ultrasound uses sound waves to create pictures of your uterus, ovaries, and surrounding structures. It can identify structural problems such as uterine fibroids (non-cancerous growths in the uterus), polyps (small growths on the lining of the uterus or cervix), or abnormalities in the thickness of the uterine lining. In many cases, a transvaginal ultrasound is performed, where a small ultrasound device is inserted into the vagina to provide clearer, more detailed images of the reproductive organs.^[8]

For more detailed examination of the uterine cavity, a procedure called sonohysterography may be performed. This involves injecting a saline solution into the uterus during an ultrasound to help visualize the lining more clearly and identify polyps or other masses that might not be visible on a standard ultrasound.^[8]

An endometrial biopsy is a procedure where a small sample of tissue is removed from the lining of the uterus (endometrium) for examination under a microscope. This test is particularly important for diagnosing cancer or precancerous conditions of the uterus, especially in women over 45 or those with risk factors for endometrial cancer. The procedure can often be performed in a clinic setting and involves inserting a thin instrument through the cervix to collect the tissue sample.^[12]

Hysteroscopy is a diagnostic procedure that allows your healthcare provider to look directly inside your uterus. A narrow, lighted tube with a small camera (called a hysteroscope) is inserted through the vagina and cervix into the uterus. This enables the doctor to see fibroids, polyps, or other abnormalities directly and, in some cases, remove them during the same procedure. Hysteroscopy can be performed in an office setting or in an operating room, depending on the situation.^[8]

In certain situations, more advanced imaging may be necessary. Magnetic resonance imaging (MRI) of the pelvis provides detailed images of the uterus and surrounding structures and is particularly useful after ultrasound when providers need to better visualize fibroids, assess for cancer, or evaluate other complex conditions. MRI uses magnets and radio waves rather than radiation to create images.^[8]

The PALM-COEIN classification system is often used by healthcare providers to organize the potential causes of abnormal uterine bleeding into structural and non-structural categories. The structural causes (PALM) include Polyps, Adenomyosis (where the uterine lining grows into the uterine wall), Leiomyoma (fibroids), and Malignancy or hyperplasia (cancer or thickening of the uterine lining). The non-structural causes (COEIN) include Coagulopathy (bleeding disorders), Ovulatory dysfunction (irregular or absent ovulation), Endometrial issues, Iatrogenic causes (related to medications like birth control), and causes Not yet classified. This system helps guide the diagnostic approach.^[5]

Diagnostics for Clinical Trial Qualification

When patients with abnormal vaginal bleeding are considered for enrollment in clinical trials, standardized diagnostic criteria are typically required to ensure participants have similar conditions and to measure outcomes accurately. The specific tests and procedures used for trial qualification depend on the trial’s focus and the condition being studied.

Initial assessment for trial qualification generally includes prompt evaluation for signs of hypovolemia (low blood volume due to blood loss) and potential hemodynamic instability, meaning the patient’s blood pressure and heart rate are stable. For acute abnormal uterine bleeding trials, patients are assessed to determine if the bleeding is of sufficient quantity to require immediate intervention.^[11]

Comprehensive blood testing is standard for clinical trial screening. This typically includes a complete blood count to assess for anemia and to establish baseline hemoglobin and iron levels before any intervention begins. Thyroid function tests are commonly performed, as thyroid disorders frequently contribute to abnormal bleeding. Tests for bleeding disorders, such as measurements of blood clotting factors, may be required, particularly for trials investigating bleeding in younger women or those with lifelong heavy periods.^[4]

Pregnancy must be definitively ruled out before enrolling patients of reproductive age in most clinical trials, as pregnancy can cause bleeding and because many trial interventions are not safe during pregnancy. A urine or blood pregnancy test is typically mandatory as part of the screening process.^[11]

Structural causes of bleeding are usually evaluated using pelvic ultrasound, which serves as a standardized baseline assessment. Trials may specify particular ultrasound findings as inclusion or exclusion criteria. For example, trials studying treatments for fibroids may require participants to have fibroids of a certain size documented by ultrasound, while excluding those with other structural abnormalities.^[8]

Endometrial assessment is frequently required for trial participation, particularly in studies involving women over a certain age or those taking hormonal treatments. An endometrial biopsy may be performed to rule out endometrial cancer or hyperplasia, as these conditions often exclude patients from trials testing medical management of bleeding. The results help ensure patient safety and trial integrity.^[12]

Clinical trials often require detailed documentation of bleeding patterns before enrollment. Participants may be asked to keep a menstrual diary for one to three months prior to joining the study, recording the start and end dates of bleeding episodes, the volume of blood loss (often quantified by the number of pads or tampons used), and associated symptoms. This baseline data is essential for measuring whether trial interventions effectively reduce bleeding.^[12]

Cervical screening with Pap testing and HPV testing may be required as part of pre-trial evaluation to ensure participants do not have cervical disease that could confound study results or compromise safety. Similarly, testing for sexually transmitted infections might be performed if the trial involves procedures or medications that could increase infection risk.^[12]

Advanced imaging such as MRI may be required for certain trials, particularly those investigating surgical interventions or comparing different treatment modalities for conditions like adenomyosis or large fibroids. These detailed images provide standardized measurements that can be used to track changes throughout the study.^[8]

For trials studying medications to manage bleeding, baseline liver and kidney function tests may be required to ensure participants can safely metabolize and eliminate the study drugs. These tests also establish baseline values that can be monitored throughout the trial for safety purposes.

The PALM-COEIN classification system is frequently used in clinical trial protocols to categorize participants according to the likely cause of their bleeding. This allows researchers to analyze whether treatments work differently for various causes of abnormal uterine bleeding and helps ensure study populations are well-defined and comparable across different research sites.^[5]